EPCAM and cholangiocarcinoma: The strongest EPCAM expression was seen in adenocarcinomas from the GI tract, i.e., small bowel, colon, pancreas, and cholangiocarcinomas but, also, in intestinal and diffuse gastric carcinomas, although gastric foveolar epithelium was EPCAM-negative.